Oxycodone hydrochloride - SpecGx
Alternative Names: Abuse deterrent oxycodone - Mallinckrodt; MNK-812Latest Information Update: 08 Jan 2022
At a glance
- Originator SpecGx
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 23 Mar 2021 No development reported - Preregistration for Pain in USA (PO)
- 12 Dec 2018 SpecGx receives complete response letter from the US FDA for roxicodone in Pain
- 14 Nov 2018 US FDA's Anaesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee vote in favour of approving oxycodone hydrochloride for treatment of Pain